𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long–term survival of Parkinson's disease

✍ Scribed by M. D'Amelio; P. Ragonese; L. Morgante; A. Reggio; G. Callari; G. Salemi; G. Savettieri

Publisher
Springer
Year
2005
Tongue
English
Weight
234 KB
Volume
253
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term results with cisapride in Park
Long-term results with cisapride in Parkinson's disease
✍ Dr. med. Wolfgang H. Jost; Klaus Schimrigk 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 220 KB

## Abstract In this study, we examined whether there is a longterm effect of cisapride on colonic transit in Parkinson's disease. Twenty‐five patients (11 women, 14 men; average age, 64.4 years; moderate symptoms) were studied and treated initially with cisapride, 5 mg, twice a day, and after the f

Long-term antidyskinetic efficacy of ama
Long-term antidyskinetic efficacy of amantadine in Parkinson's disease
✍ Elisabeth Wolf; Klaus Seppi; Regina Katzenschlager; Guenter Hochschorner; Gerhar 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB 👁 1 views

## Abstract Several randomized placebo‐controlled trials have consistently shown antidyskinetic effects of amantadine in levodopa treated patients with advanced Parkinson's disease (PD). However, all of these were of short duration and there have been claims that the effect of amantadine on levodop

Long-term follow-up of impulse control d
Long-term follow-up of impulse control disorders in Parkinson's disease
✍ Eugenia Mamikonyan; Andrew D. Siderowf; John E. Duda; Marc N. Potenza; Stacy Hor 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB 👁 1 views

## Abstract Recent studies have linked dopamine agonist (DA) usage with the development of impulse control disorders (ICDs) in Parkinson's disease (PD). Little is known about optimal management strategies or the long‐term outcomes of affected patients. To report on the clinical interventions and lo